Rifamax 200 mg (Tablet)
Unit Price: ৳ 20.00 (1 x 10: ৳ 200.00)
Strip Price: ৳ 200.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Rifaximin |
| Company | Incepta pharmaceuticals ltd |
| Also available as |
Title
Rifamax
Categories
- Antibiotic
- Gastrointestinal Health
- Travel Medicine
Description
Rifamax is a semisynthetic, rifamycin-based non-systemic antibiotic indicated for the treatment of traveler's diarrhea, reduction in risk of overt hepatic encephalopathy, and bacterial overgrowth of irritable bowel syndrome. It inhibits bacterial RNA synthesis by its action on the beta-subunit of the DNA-dependent RNA polymerase and shows broad spectrum activity against many species of bacteria. It is available in different dosages for different indications and can be taken with or without food. However, it is contraindicated in patients with hypersensitivity to Rifaximin or any rifamycin antimicrobial agents, and has various side effects and precautions.
Attributes
- Indications:
- Traveler's diarrhea
- Reduction in risk of overt hepatic encephalopathy
- Bacterial overgrowth of irritable bowel syndrome
- Pharmacology:
- Inhibition of bacterial RNA synthesis
- Broad spectrum bactericidal action
- Non-systemic antibiotic
- Dosage & Administration:
- Dosages for different indications
- Can be taken with or without food
- Interaction:
- Potential induction of CYP3A4
- Expected effects in patients with normal liver function
- Contraindications:
- Hypersensitivity to Rifaximin or rifamycin antimicrobial agents
- Side Effects:
- Flatulence
- Headache
- Abdominal pain
- Rectal tenesmus
- Defecation urgency
- Nausea
- Constipation
- Pyrexia
- Vomiting
- Anaphylaxis
- Angioneurotic edema
- Exfoliative dermatitis
- Pregnancy & Lactation:
- Pregnancy category C
- Unknown excretion in human milk
- Precautions & Warnings:
- Ineffectiveness in diarrhea complicated by fever and/or blood in the stools
- Possible pseudomembranous colitis
- Discontinuation if symptoms worsen or persist
- Consideration of alternative antibiotic therapy
- Use in Special Populations:
- Unstudied pharmacokinetics in renal impairment
- Markedly elevated systemic exposure in hepatic impairment
- Overdose Effects:
- No specific information available for treatment
- Therapeutic Class:
- 4-Quinolone preparations
- Storage Conditions:
- Keep below 30°C
- Away from light & moisture
- Keep out of the reach of children